BDNF Signaling in Vascular Dementia and Its Effects on Cerebrovascular Dysfunction, Synaptic Plasticity, and Cholinergic System Abnormality

키워드

참고문헌 (201)

1. Wu YT, "The changing prevalence and incidence of dementia over time-current evidence", Nat Rev Neurol, 13, pp.327~339 (2017)
2. Prince M, "The global prevalence of dementia : a systematic review and metaanalysis", Alzheimers Dement, 9, pp.63~75 (2013)
3. Velandia PP, "Global and regional spending on dementia care from 2000-2019 and expected future health spending scenarios from 2020-2050 : an economic modelling exercise", EClinicalMedicine, 45, pp.101337~ (2022)
4. Wortmann M, "Dementia : a global health priority-highlights from an ADI and World Health Organization report", Alzheimers Res Ther, 4, pp.40~ (2012)
5. Grinberg LT, "Toward a pathological definition of vascular dementia", J Neurol Sci, 299, pp.136~138 (2010)
6. Graff-Radford J, "Vascular cognitive impairment", Continuum(Minneap Minn), 25, pp.147~164 (2019)
7. Ueno M, "Blood-brain barrier damage in vascular dementia", Neuropathology, 36, pp.115~124 (2016)
8. Li C, "Pathological changes in neurovascular units : lessons from cases of vascular dementia", CNS Neurosci Ther, 27, pp.17~25 (2021)
9. Tapia-Arancibia L, "Physiology of BDNF : focus on hypothalamic function", Front Neuroendocrinol, 25, pp.77~107 (2004)
10. Buhusi M, "Increased hippocampal proBDNF contributes to memory impairments in aged mice", Front Aging Neurosci, 9, pp.284~ (2017)
11. Ng TK, "Decreased serum brain-derived neurotrophic factor(BDNF)levels in patients with Alzheimer’s disease(AD) : a systematic review and meta-analysis", Int J Mol Sci, 20, pp.257~ (2019)
12. Benraiss A, "Adenoviral brain-derived neurotrophic factor induces both neostriatal and olfactory neuronal recruitment from endogenous progenitor cells in the adult forebrain", J Neurosci, 21, pp.6718~6731 (2001)
13. Binder DK, "Brain-derived neurotrophic factor", Growth Factors, 22, pp.123~131 (2004)
14. Bramham CR, "BDNF function in adult synaptic plasticity : the synaptic consolidation hypothesis", Prog Neurobiol, 76, pp.99~125 (2005)
15. O’Brien JT, "Vascular dementia", Lancet, 386, pp.1698~1706 (2015)
16. Kalaria RN, "The pathology and pathophysiology of vascular dementia", Neuropharmacology, 134, pp.226~239 (2018)
17. Battle DE, "Diagnostic and Statistical Manual of Mental Disorders(DSM)", Codas, 25, pp.191~192 (2013)
18. Rizzi L, "Global epidemiology of dementia : Alzheimer’s and vascular types", BioMed Res Int, 2014, pp.908915~ (2014)
19. Rosa G, "Brain aging, cardiovascular diseases, mixed dementia, and frailty in the oldest old : from brain phenotype to clinical expression", J Alzheimers Dis, 75, pp.1083~1103 (2020)
20. Gorelick PB, "Vascular cognitive impairment and dementia", Biochim Biophys Acta, 1862, pp.860~868 (2016)
21. Faraco G, "Hypertension : a harbinger of stroke and dementia", Hypertension, 62, pp.810~817 (2013)
22. Pendlebury ST, "Incidence and prevalence of dementia associated with transient ischaemic attack and stroke : analysis of the population-based Oxford Vascular Study", Lancet Neurol, 18, pp.248~258 (2019)
23. Iadecola C, "Vascular cognitive impairment and dementia : JACC Scientific Expert Panel", J Am Coll Cardiol, 73, pp.3326~3344 (2019)
24. Kalaria RN, "Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer’s disease", Acta Neuropathol, 131, pp.659~685 (2016)
25. Sonnen JA, "Pathological correlates of dementia in a longitudinal, population-based sample of aging", Ann Neurol, 62, pp.406~413 (2007)
26. van de Pol L, "Hippocampal atrophy in subcortical vascular dementia", Neurodegener Dis, 8, pp.465~469 (2011)
27. Wang J, "Cholinergic deficiency involved in vascular dementia : possible mechanism and strategy of treatment", Acta Pharmacol Sin, 30, pp.879~888 (2009)
28. van Gool WA, "Systemic infection and delirium : when cytokines and acetylcholine collide", Lancet, 375, pp.773~775 (2010)
29. Farrall AJ, "Blood-brain barrier : ageing and microvascular disease--systematic review and meta-analysis", Neurobiol Aging, 30, pp.337~352 (2009)
30. Wong SM, "Blood-brain barrier impairment and hypoperfusion are linked in cerebral small vessel disease", Neurology, 92, pp.e1669~ (2019)
31. Ueno M, "Blood-brain barrier disruption in white matter lesions in a rat model of chronic cerebral hypoperfusion", J Cereb Blood Flow Metab, 22, pp.97~104 (2002)
32. Stebbins GT, "Gray matter atrophy in patients with ischemic stroke with cognitive impairment", Stroke, 39, pp.785~793 (2008)
33. Strozyk D, "Contribution of vascular pathology to the clinical expression of dementia", Neurobiol Aging, 31, pp.1710~1720 (2010)
34. Marshall GA, "White matter hyperintensities and cortical acetylcholinesterase activity in parkinsonian dementia", Acta Neurol Scand, 113, pp.87~91 (2006)
35. Kim JO, "Effect of acetylcholinesterase inhibitors on post-stroke cognitive impairment and vascular dementia : a meta-analysis", PLoS One, 15, pp.e0227820~ (2020)
36. Dwyer R, "Using Alzgene-like approaches to investigate susceptibility genes for vascular cognitive impairment", J Alzheimers Dis, 34, pp.145~154 (2013)
37. Yin YW, "Association between apolipoprotein E gene polymorphism and the risk of vascular dementia : a meta-analysis", Neurosci Lett, 514, pp.6~11 (2012)
38. Iadecola C, "The pathobiology of vascular dementia", Neuron, 80, pp.844~866 (2013)
39. Markus HS, "Genetics of vascular cognitive impairment", Stroke, 50, pp.765~772 (2019)
40. Skrobot OA, "Progress toward standardized diagnosis of vascular cognitive impairment : guidelines from the Vascular Impairment of Cognition Classification Consensus Study", Alzheimers Dement, 14, pp.280~292 (2018)
41. Skrobot OA, "The Vascular Impairment of Cognition Classification Consensus Study", Alzheimers Dement, 13, pp.624~633 (2017)
42. Hachinski V, "National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards", Stroke, 37, pp.2220~2241 (2006)
43. Roseborough A, "White matter degeneration-a treatable target?", JAMA Neurol, 77, pp.793~794 (2020)
44. Debette S, "The clinical importance of white matter hyperintensities on brain magnetic resonance imaging : systematic review and meta-analysis", BMJ, 341, pp.c3666~ (2010)
45. Hase Y, "White matter degeneration in vascular and other ageing-related dementias", J Neurochem, 144, pp.617~633 (2018)
46. Grinberg LT, "Vascular pathology in the aged human brain", Acta Neuropathol, 119, pp.277~290 (2010)
47. Prins ND, "Cerebral small-vessel disease and decline in information processing speed, executive function and memory", Brain, 128, pp.2034~2041 (2005)
48. Uiterwijk R, "MRI progression of cerebral small vessel disease and cognitive decline in patients with hypertension", J Hypertens, 35, pp.1263~1270 (2017)
49. van den Berg E, "White matter hyperintensities and cognition in mild cognitive impairment and Alzheimer’s disease : a domain-specific meta-analysis", J Alzheimers Dis, 63, pp.515~527 (2018)
50. Huang EJ, "Neurotrophins : roles in neuronal development and function", Annu Rev Neurosci, 24, pp.677~736 (2001)
51. Bekinschtein P, "BDNF and memory processing", Neuropharmacology, 76, pp.677~683 (2014)
52. Timmusk T, "Multiple promoters direct tissue-specific expression of the rat BDNF gene", Neuron, 10, pp.475~489 (1993)
53. Wardle RA, "Brain-derived neurotrophic factor modulation of GABAergic synapses by postsynaptic regulation of chloride transport", J Neurosci, 23, pp.8722~8732 (2003)
54. Pan W, "Transport of brain-derived neurotrophic factor across the blood-brain barrier", Neuropharmacology, 37, pp.1553~1561 (1998)
55. Klein AB, "Blood BDNF concentrations reflect brain-tissue BDNF levels across species", Int J Neuropsychopharmacol, 14, pp.347~353 (2011)
56. Pang PT, "Cleavage of proBDNF by tPA", plasmin is essential for long-term hippocampal plasticity, 2004, pp.306, 487~491
57. Ahmed AO, "Brain-derived neurotrophic factor(BDNF)and neurocognitive deficits in people with schizophrenia : a meta-analysis", Psychiatry Res, 226, pp.1~13 (2015)
58. Greenberg ME, "New insights in the biology of BDNF synthesis and release : implications in CNS function", J Neurosci, 29, pp.12764~12767 (2009)
59. Forlenza OV, "Decreased neurotrophic support is associated with cognitive decline in non-demented subjects", J Alzheimers Dis, 46, pp.423~429 (2015)
60. Ventriglia M, "Serum brain-derived neurotrophic factor levels in different neurological diseases", BioMed Res Int, 2013, pp.901082~ (2013)
61. Weinstein G, "Serum brain-derived neurotrophic factor and the risk for dementia : the Framingham Heart Study", JAMA Neurol, 71, pp.55~61 (2014)
62. Forlenza OV, "Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment", World J Biol Psychiatry, 11, pp.774~780 (2010)
63. Peng S, "Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer’s disease", J Neurochem, 93, pp.1412~1421 (2005)
64. Nakai S, "Effects of BDNF infusion on the axon terminals of locus coeruleus neurons of aging rats", Neurosci Res, 54, pp.213~219 (2006)
65. Matsunaga W, "BDNF is necessary for maintenance of noradrenergic innervations in the aged rat brain", Neurobiol Aging, 25, pp.341~348 (2004)
66. Scott Bitner R, "Cyclic AMP response element-binding protein(CREB)phosphorylation : a mechanistic marker in the development of memory enhancing Alzheimer’s disease therapeutics", Biochem Pharmacol, 83, pp.705~714 (2012)
67. Choi SH, "Combined adult neurogenesis and BDNF mimic exercise effects on cognition in an Alzheimer’s mouse model", Science, 361, pp.eaan8821~ (2018)
68. Figurov A, "Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus", Nature, 381, pp.706~709 (1996)
69. Hu YS, "Molecular mechanisms of environmental enrichment : impairments in Akt", GSK3β, neurotrophin-3 and CREB signaling, 2013, pp.8, e64460~
70. Lu Y, "BDNF : a key regulator for protein synthesis-dependent LTP and long-term memory?", Neurobiol Learn Mem, 89, pp.312~323 (2008)
71. Alonso M, "ERK1", 2 activation is necessary for BDNF to increase dendritic spine density in hippocampal CA1 pyramidal neurons, 2004, pp.11, 172~178
72. Pláteník J, "GSK3β, CREB, and BDNF in peripheral blood of patients with Alzheimer’s disease and depression", Prog Neuropsychopharmacol Biol Psychiatry, 50, pp.83~93 (2014)
73. Di Loreto S, "Regular and moderate exercise initiated in middle age prevents age-related amyloidogenesis and preserves synaptic and neuroprotective signaling in mouse brain cortex", Exp Gerontol, 57, pp.57~65 (2014)
74. Erickson KI, "Exercise training increases size of hippocampus and improves memory", Proc Natl Acad Sci U S A, 108, pp.3017~3022 (2011)
75. Caldeira MV, "BDNF regulates the expression and traffic of NMDA receptors in cultured hippocampal neurons", Mol Cell Neurosci, 35, pp.208~219 (2007)
76. Villeneuve S, "Vascular risk and Aβ interact to reduce cortical thickness in AD vulnerable brain regions", Neurology, 83, pp.40~47 (2014)
77. Shih AY, "Rodent models of cerebral microinfarct and microhemorrhage", Stroke, 49, pp.803~810 (2018)
78. Venkat P, "Models and mechanisms of vascular dementia", Exp Neurol, 272, pp.97~108 (2015)
79. Maki T, "Biphasic mechanisms of neurovascular unit injury and protection in CNS diseases", CNS Neurol Disord Drug Targets, 12, pp.302~315 (2013)
80. Armulik A, "Pericytes regulate the blood-brain barrier", Nature, 468, pp.557~561 (2010)
81. Winkler EA, "Central nervous system pericytes in health and disease", Nat Neurosci, 14, pp.1398~1405 (2011)
82. Muoio V, "The neurovascular unit-concept review", Acta Physiol(Oxf), 210, pp.790~798 (2014)
83. Rosenberg GA, "Neurological diseases in relation to the blood-brain barrier", J Cereb Blood Flow Metab, 32, pp.1139~1151 (2012)
84. Wallin A, "Blood brain barrier function in vascular dementia", Acta Neurol Scand, 81, pp.318~322 (1990)
85. Koizumi T, "Transiently proliferating perivascular microglia harbor M1 type and precede cerebrovascular changes in a chronic hypertension model", J Neuroinflammation, 16, pp.79~ (2019)
86. Jiang X, "Blood-brain barrier dysfunction and recovery after ischemic stroke", Prog Neurobiol, 163-164, pp.144~171 (2018)
87. Donnan GA, "Stroke", Lancet, 371, pp.1612~1623 (2008)
88. Jellinger KA, "Pathology and pathogenesis of vascular cognitive impairment-a critical update", Front Aging Neurosci, 5, pp.17~ (2013)
89. Gorelick PB, "Vascular contributions to cognitive impairment and dementia : a statement for healthcare professionals from the American Heart Association", American Stroke Association, 2011, pp.42, 2672~2713
90. Lind BL, "Rapid stimulus-evoked astrocyte Ca2+ elevations and hemodynamic responses in mouse somatosensory cortex in vivo", Proc Natl Acad Sci U S A, 110, pp.E4678~ (2013)
91. Abbott NJ, "Astrocyte-endothelial interactions and blood-brain barrier permeability", J Anat, 200, pp.629~638 (2002)
92. Mathiisen TM, "The perivascular astroglial sheath provides a complete covering of the brain microvessels : an electron microscopic 3D reconstruction", Glia, 58, pp.1094~1103 (2010)
93. Allen NJ, "Cell biology of astrocyte-synapse interactions", Neuron, 96, pp.697~708 (2017)
94. Liddelow SA, "Neurotoxic reactive astrocytes are induced by activated microglia", Nature, 541, pp.481~487 (2017)
95. Patabendige A, "Astrocyte activation in neurovascular damage and repair following ischaemic stroke", Int J Mol Sci, 22, pp.4280~ (2021)
96. Skowrońska M, "Oxidative and nitrosative stress in ammonia neurotoxicity", Neurochem Int, 62, pp.731~737 (2013)
97. Semyanov A, "Astrocytic processes : from tripartite synapses to the active milieu", Trends Neurosci, 44, pp.781~792 (2021)
98. Eroglu C, "Regulation of synaptic connectivity by glia", Nature, 468, pp.223~231 (2010)
99. Spampinato SF, "Astrocyte-derived paracrine signals : relevance for neurogenic niche regulation and blood-brain barrier integrity", Front Pharmacol, 10, pp.1346~ (2019)
100. Lécuyer MA, "Glial influences on BBB functions and molecular players in immune cell trafficking", Biochim Biophys Acta, 1862, pp.472~482 (2016)
101. Rosenegger DG, "Tonic local brain blood flow control by astrocytes independent of phasic neurovascular coupling", J Neurosci, 35, pp.13463~13474 (2015)
102. Cauli B, "Cortical GABA interneurons in neurovascular coupling : relays for subcortical vasoactive pathways", J Neurosci, 24, pp.8940~8949 (2004)
103. Hu H, "Interneurons. Fast-spiking, parvalbumin+ GABAergic interneurons : from cellular design to microcircuit function", Science, 345, pp.1255263~ (2014)
104. Zhang LY, "Microglia exacerbate white matter injury via complement C3", C3aR pathway after hypoperfusion, 2020, pp.10, 74~90
105. Qin C, "Fingolimod protects against ischemic white matter damage by modulating microglia toward M2 polarization via STAT3 pathway", Stroke, 48, pp.3336~3346 (2017)
106. Lee J, "Heterogeneity of microglia and their differential roles in white matter pathology", CNS Neurosci Ther, 25, pp.1290~1298 (2019)
107. Bangen KJ, "Baseline white matter hyperintensities and hippocampal volume are associated with conversion from normal cognition to mild cognitive impairment in the Framingham Offspring Study", Alzheimer Dis Assoc Disord, 32, pp.50~56 (2018)
108. Lee S, "White matter hyperintensities are a core feature of Alzheimer’s disease : evidence from the dominantly inherited Alzheimer network", Ann Neurol, 79, pp.929~939 (2016)
109. Brickman AM, "Reconsidering harbingers of dementia : progression of parietal lobe white matter hyperintensities predicts Alzheimer’s disease incidence", Neurobiol Aging, 36, pp.27~32 (2015)
110. Wardlaw JM, "What are white matter hyperintensities made of? Relevance to vascular cognitive impairment", J Am Heart Assoc, 4, pp.001140~ (2015)
111. Alber J, "White matter hyperintensities in vascular contributions to cognitive impairment and dementia(VCID) : knowledge gaps and opportunities", Alzheimers Dement(N Y), 5, pp.107~117 (2019)
112. Ding H, "BDNF promotes activation of astrocytes and microglia contributing to neuroinflammation and mechanical allodynia in cyclophosphamide-induced cystitis", J Neuroinflammation, 17, pp.19~ (2020)
113. Zhang Y, "Blood-brain barrier targeting of BDNF improves motor function in rats with middle cerebral artery occlusion", Brain Res, 1111, pp.227~229 (2006)
114. Grade S, "Brain-derived neurotrophic factor promotes vasculature-associated migration of neuronal precursors toward the ischemic striatum", PLoS One, 8, pp.e55039~ (2013)
115. Kermani P, "Neurotrophins promote revascularization by local recruitment of TrkB+ endothelial cells and systemic mobilization of hematopoietic progenitors", J Clin Invest, 115, pp.653~663 (2005)
116. Kim MS, "Mumefural improves recognition memory and alters ERK-CREB-BDNF signaling in a mouse model of chronic cerebral hypoperfusion", Nutrients, 15, pp.3271~ (2023)
117. Snapyan M, "Vasculature guides migrating neuronal precursors in the adult mammalian forebrain via brain-derived neurotrophic factor signaling", J Neurosci, 29, pp.4172~4188 (2009)
118. Brenner EK, "Brain derived neurotrophic factor interacts with white matter hyperintensities to influence processing speed and hippocampal volume in older adults", J Alzheimers Dis, 93, pp.141~149 (2023)
119. Géral C, "From molecular to nanotechnology strategies for delivery of neurotrophins : emphasis on brain-derived neurotrophic factor(BDNF)", Pharmaceutics, 5, pp.127~167 (2013)
120. Holt LM, "Astrocyte morphogenesis is dependent on BDNF signaling via astrocytic TrkB. T1", eLife, 8, pp.e44667~ (2019)
121. Bonvento G, "Astrocyte-neuron metabolic cooperation shapes brain activity", Cell Metab, 33, pp.1546~1564 (2021)
122. Kinboshi M, "Inhibition of inwardly rectifying potassium(Kir)4. 1 channels facilitates brain-derived neurotrophic factor(BDNF)expression in astrocytes", Front Mol Neurosci, 10, pp.408~ (2017)
123. Alderson RF, "Truncated TrkB mediates the endocytosis and release of BDNF and neurotrophin-4", 5 by rat astrocytes and Schwann cells in vitro, 2000, pp.871, 210~222
124. Kabba JA, "Microglia : housekeeper of the central nervous system", Cell Mol Neurobiol, 38, pp.53~71 (2018)
125. Haruwaka K, "Dual microglia effects on blood brain barrier permeability induced by systemic inflammation", Nat Commun, 10, pp.5816~ (2019)
126. Long T, "Microglia P2X4R-BDNF signalling contributes to central sensitization in a recurrent nitroglycerin-induced chronic migraine model", J Headache Pain, 21, pp.4~ (2020)
127. Charlton T, "Brain-derived neurotrophic factor(BDNF)has direct anti-inflammatory effects on microglia", Front Cell Neurosci, 17, pp.1188672~ (2023)
128. Weon JB, "Cognitive-enhancing effect of Dianthus superbus var. Longicalycinus on scopolamine-induced memory impairment in mice", Biomol Ther(Seoul), 24, pp.298~304 (2016)
129. Farlow MR, "A modern hypothesis : the distinct pathologies of dementia associated with Parkinson’s disease versus Alzheimer’s disease", Dement Geriatr Cogn Disord, 25, pp.301~308 (2008)
130. Orciani C, "Long-term nucleus basalis cholinergic depletion induces attentional deficits and impacts cortical neurons and BDNF levels without affecting the NGF synthesis", J Neurochem, 163, pp.149~167 (2022)
131. Ferreira-Vieira TH, "Alzheimer’s disease : targeting the cholinergic system", Curr Neuropharmacol, 14, pp.101~115 (2016)
132. Maurer SV, "The cholinergic system modulates memory and hippocampal plasticity via its interactions with non-neuronal cells", Front Immunol, 8, pp.1489~ (2017)
133. Han Y, "Schisanhenol improves learning and memory in scopolamine-treated mice by reducing acetylcholinesterase activity and attenuating oxidative damage through SIRT1-PGC-1α-Tau signaling pathway", Int J Neurosci, 129, pp.110~118 (2019)
134. Gottfries CG, "The neurochemistry of vascular dementia", Dementia, 5, pp.163~167 (1994)
135. Court JA, "Neurotransmitter abnormalities in vascular dementia", Int Psychogeriatr, 15(Suppl 1), pp.81~87 (2003)
136. Kumaran D, "Involvement of angiotensin converting enzyme in cerebral hypoperfusion induced anterograde memory impairment and cholinergic dysfunction in rats", Neuroscience, 155, pp.626~639 (2008)
137. Pavlov VA, "The cholinergic anti-inflammatory pathway", Brain Behav Immun, 19, pp.493~499 (2005)
138. Román GC, "Cholinergic dysfunction in vascular dementia", Curr Psychiatry Rep, 7, pp.18~26 (2005)
139. Román GC, "Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia", Neurobiol Aging, 27, pp.1769~1785 (2006)
140. Borlongan CV, "Methanesulfonyl fluoride, an acetylcholinesterase inhibitor, attenuates simple learning and memory deficits in ischemic rats", Brain Res, 1038, pp.50~58 (2005)
141. Naritomi H, "Experimental basis of multi-infarct dementia : memory impairments in rodent models of ischemia", Alzheimer Dis Assoc Disord, 5, pp.103~111 (1991)
142. Kalaria R, "Similarities between Alzheimer’s disease and vascular dementia", J Neurol Sci, 203-204, pp.29~34 (2002)
143. Liu B, "Autophagy activation aggravates neuronal injury in the hippocampus of vascular dementia rats", Neural Regen Res, 9, pp.1288~1296 (2014)
144. Dong J, "Exercise improves recognition memory and synaptic plasticity in the prefrontal cortex for rats modelling vascular dementia", Neurol Res, 40, pp.68~77 (2018)
145. Grossberg S, "From brain synapses to systems for learning and memory : object recognition, spatial navigation, timed conditioning, and movement control", Brain Res, 1621, pp.270~293 (2015)
146. Yuen EY, "Postsynaptic density-95(PSD-95)and calcineurin control the sensitivity of N-methyl-D-aspartate receptors to calpain cleavage in cortical neurons", Mol Pharmacol, 74, pp.360~370 (2008)
147. Sinclair LI, "Synaptic protein levels altered in vascular dementia", Neuropathol Appl Neurobiol, 41, pp.533~543 (2015)
148. Liu B, "Effects of autophagy on synaptic-plasticity-related protein expression in the hippocampus CA1 of a rat model of vascular dementia", Neurosci Lett, 707, pp.134312~ (2019)
149. Lee SH, "Aqueous extract of Cordyceps alleviates cerebral ischemia-induced short-term memory impairment in gerbils", J Exerc Rehabil, 12, pp.69~78 (2016)
150. Sawamoto A, "3, 5, 6, 7, 8, 3′, 4′-Heptamethoxyflavone, a citrus flavonoid, ameliorates corticosterone-induced depression-like behavior and restores brain-derived neurotrophic factor expression, neurogenesis, and neuroplasticity in the hippocampus", Molecules, 21, pp.541~ (2016)
151. Koshimizu H, "Brain-derived neurotrophic factor predominantly regulates the expression of synapse-related genes in the striatum : insights from in vitro transcriptomics", Neuropsychopharmacol Rep, 41, pp.485~495 (2021)
152. Khakh BS, "Diversity of astrocyte functions and phenotypes in neural circuits", Nat Neurosci, 18, pp.942~952 (2015)
153. Allen NJ, "Glia as architects of central nervous system formation and function", Science, 362, pp.181~185 (2018)
154. Durkee CA, "Diversity and specificity of astrocyte-neuron communication", Neuroscience, 396, pp.73~78 (2019)
155. Bergami M, "Uptake and recycling of pro-BDNF for transmitter-induced secretion by cortical astrocytes", J Cell Biol, 183, pp.213~221 (2008)
156. Chen Z, "Necroptotic astrocytes induced neuronal apoptosis partially through EVs-derived pro-BDNF", Brain Res Bull, 177, pp.73~80 (2021)
157. de Pins B, "Conditional BDNF delivery from astrocytes rescues memory deficits, spine density, and synaptic properties in the 5xFAD mouse model of Alzheimer disease", J Neurosci, 39, pp.2441~2458 (2019)
158. Vignoli B, "Peri-synaptic glia recycles brain-derived neurotrophic factor for LTP stabilization and memory retention", Neuron, 92, pp.873~887 (2016)
159. Lu B, "BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases", Nat Rev Neurosci, 14, pp.401~416 (2013)
160. Fernández-García S, "Astrocytic BDNF and TrkB regulate severity and neuronal activity in mouse models of temporal lobe epilepsy", Cell Death Dis, 11, pp.411~ (2020)
161. Alonso M, "BDNF-triggered events in the rat hippocampus are required for both short-and long-term memory formation", Hippocampus, 12, pp.551~560 (2002)
162. Choudhary AK, "Neurophysiological symptoms and aspartame : what is the connection?", Nutr Neurosci, 21, pp.306~316 (2018)
163. Kutlu MG, "Effects of drugs of abuse on hippocampal plasticity and hippocampus-dependent learning and memory : contributions to development and maintenance of addiction", Learn Mem, 23, pp.515~533 (2016)
164. Babu H, "Synaptic network activity induces neuronal differentiation of adult hippocampal precursor cells through BDNF signaling", Front Neurosci, 3, pp.49~ (2009)
165. Gutiérrez-Vargas JA, "CDK5 knockdown prevents hippocampal degeneration and cognitive dysfunction produced by cerebral ischemia", J Cereb Blood Flow Metab, 35, pp.1937~1949 (2015)
166. Sweatt JD, "The neuronal MAP kinase cascade : a biochemical signal integration system subserving synaptic plasticity and memory", J Neurochem, 76, pp.1~10 (2001)
167. Cunha C, "A simple role for BDNF in learning and memory?", Front Mol Neurosci, 3, pp.1~ (2010)
168. Jiang T, "Genistein attenuates isoflurane-induced neurotoxicity and improves impaired spatial learning and memory by regulating cAMP", CREB and BDNF-TrkB-PI3K, Korean J Physiol Pharmacol, pp.2017, 21[DOI]
169. Lu B, "BDNF and activity-dependent synaptic modulation", Learn Mem, 10, pp.86~98 (2003)
170. Tartaglia N, "Protein synthesis-dependent and-independent regulation of hippocampal synapses by brain-derived neurotrophic factor", J Biol Chem, 276, pp.37585~37593 (2001)
171. Yoshii A, "Postsynaptic localization of PSD-95 is regulated by all three pathways downstream of TrkB signaling", Front Synaptic Neurosci, 6, pp.6~ (2014)
172. Yuan J, "Electroacupuncture improves learning and memory impairment and enhances hippocampal synaptic plasticity through BDNF", TRKB, Zhen Ci Yan Jiu, pp.2023, 48[DOI]
173. Swain M, "Brain-derived neurotrophic factor protects neurons by stimulating mitochondrial function through protein kinase A", J Neurochem, 167, pp.104~125 (2023)
174. Wang W, "Microglial repopulation reverses cognitive and synaptic deficits in an Alzheimer’s disease model by restoring BDNF signaling", Brain Behav Immun, 113, pp.275~288 (2023)
175. Tyler WJ, "From acquisition to consolidation : on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning", Learn Mem, 9, pp.224~237 (2002)
176. Murer MG, "Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease", Prog Neurobiol, 63, pp.71~124 (2001)
177. Sartori CR, "The antidepressive effect of the physical exercise correlates with increased levels of mature BDNF, and proBDNF proteolytic cleavage-related genes, p11 and tPA", Neuroscience, 180, pp.9~18 (2011)
178. Leckie RL, "BDNF mediates improvements in executive function following a 1-year exercise intervention", Front Hum Neurosci, 8, pp.985~ (2014)
179. Erickson KI, "Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume", J Neurosci, 30, pp.5368~5375 (2010)
180. Lee JG, "Decreased serum brain-derived neurotrophic factor levels in elderly Korean with dementia", Psychiatry Investig, 6, pp.299~305 (2009)
181. Yasutake C, "Serum BDNF, TNF-alpha and IL-1beta levels in dementia patients : comparison between Alzheimer’s disease and vascular dementia", Eur Arch Psychiatry Clin Neurosci, 256, pp.402~406 (2006)
182. Woo NH, "Activation of p75NTR by proBDNF facilitates hippocampal long-term depression", Nat Neurosci, 8, pp.1069~1077 (2005)
183. Yang J, "proBDNF negatively regulates neuronal remodeling, synaptic transmission, and synaptic plasticity in hippocampus", Cell Reports, 7, pp.796~806 (2014)
184. Chen J, "proBDNF accelerates brain amyloid-β deposition and learning and memory impairment in APPswePS1dE9 transgenic mice", J Alzheimers Dis, 59, pp.941~949 (2017)
185. Vetrovoĭ OV, "Effect of hypoxic postconditioning on the expression of antiapoptotic protein Bcl-2 and neurotrophin BDNF in CA1 hippocampal field of rats surviving severe hypoxia", Morfologiia, 145, pp.16~20 (2014)
186. Parkhurst CN, "Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor", Cell, 155, pp.1596~1609 (2013)
187. Sierra A, "Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis", Cell Stem Cell, 7, pp.483~495 (2010)
188. Blokland A, "Acetylcholine : a neurotransmitter for learning and memory?", Brain Res Brain Res Rev, 21, pp.285~300 (1995)
189. da Penha Berzaghi M, "Cholinergic regulation of brain-derived neurotrophic factor(BDNF)and nerve growth factor(NGF)but not neurotrophin-3(NT-3)mRNA levels in the developing rat hippocampus", J Neurosci, 13, pp.3818~3826 (1993)
190. Tyler WJ, "BDNF enhances quantal neurotransmitter release and increases the number of docked vesicles at the active zones of hippocampal excitatory synapses", J Neurosci, 21, pp.4249~4258 (2001)
191. Alderson RF, "Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture", Neuron, 5, pp.297~306 (1990)
192. Iulita MF, "Differential deregulation of NGF and BDNF neurotrophins in a transgenic rat model of Alzheimer’s disease", Neurobiol Dis, 108, pp.307~323 (2017)
193. Fahnestock M, "Neurotrophic factors and Alzheimer’s disease : are we focusing on the wrong molecule?", J Neural Transm Suppl, 62, pp.241~252 (2002)
194. Hachisu M, "Beyond the hypothesis of serum anticholinergic activity in Alzheimer’s disease : acetylcholine neuronal activity modulates brain-derived neurotrophic factor production and inflammation in the brain", Neurodegener Dis, 15, pp.182~187 (2015)
195. McNerney MW, "Repetitive transcranial magnetic stimulation improves brain-derived neurotrophic factor and cholinergic signaling in the 3xTgAD mouse model of Alzheimer’s disease", J Alzheimers Dis, 86, pp.499~507 (2022)
196. Khairy EY, "Protective effects of vitamin D on neurophysiologic alterations in brain aging : role of brain-derived neurotrophic factor(BDNF)", Nutr Neurosci, 24, pp.650~659 (2021)
197. Luo H, "Apelin-13 suppresses neuroinflammation against cognitive deficit in a streptozotocin-induced rat model of Alzheimer’s disease through activation of BDNF-TrkB signaling pathway", Front Pharmacol, 10, pp.395~ (2019)
198. Sakata K, "Promoter IV-BDNF deficiency disturbs cholinergic gene expression of CHRNA5, CHRM2, and CHRM5 : effects of drug and environmental treatments", J Neurochem, 143, pp.49~64 (2017)
199. Ward NL, "BDNF is needed for postnatal maturation of basal forebrain and neostriatum cholinergic neurons in vivo", Exp Neurol, 162, pp.297~310 (2000)
200. Slonimsky JD, "BDNF and CNTF regulate cholinergic properties of sympathetic neurons through independent mechanisms", Mol Cell Neurosci, 23, pp.648~660 (2003)
201. Gil-Bea FJ, "Cholinergic hypofunction impairs memory acquisition possibly through hippocampal Arc and BDNF downregulation", Hippocampus, 21, pp.999~1009 (2011)

관련 논문AI추천